Efficacy and safety of vemircopan as monotherapy in patients with paroxysmal nocturnal hemoglobinuria
- DOI
- 10.1182/bloodadvances.2025017731
- Published
- 2026-01-28
- Container
- Blood Advances
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2025017731,
title = {Efficacy and safety of vemircopan as monotherapy in patients with paroxysmal nocturnal hemoglobinuria},
author = {Austin Kulasekararaj and Peter Browett and Antonio M. Risitano and Christopher J. Patriquin and Mustafa N. Yenerel and Daniele Marceau and Fahri Sahin and J. Lorenzo Algarra and Masayo Ogawa and Ji Yu and Nicholas Bruce Cross and Rosario Notaro and Jong Wook Lee and Robert A. Brodsky},
year = {2026},
journal = {Blood Advances},
doi = {10.1182/bloodadvances.2025017731},
url = {https://doi.org/10.1182/bloodadvances.2025017731}
}RIS
TY - JOUR TI - Efficacy and safety of vemircopan as monotherapy in patients with paroxysmal nocturnal hemoglobinuria AU - Austin Kulasekararaj AU - Peter Browett AU - Antonio M. Risitano AU - Christopher J. Patriquin AU - Mustafa N. Yenerel AU - Daniele Marceau AU - Fahri Sahin AU - J. Lorenzo Algarra AU - Masayo Ogawa AU - Ji Yu AU - Nicholas Bruce Cross AU - Rosario Notaro AU - Jong Wook Lee AU - Robert A. Brodsky PY - 2026 JO - Blood Advances DO - 10.1182/bloodadvances.2025017731 UR - https://doi.org/10.1182/bloodadvances.2025017731 ER -
APA
Kulasekararaj, A., Browett, P., Risitano, A. M., Patriquin, C. J., Yenerel, M. N., Marceau, D., Sahin, F., Algarra, J. L., Ogawa, M., Yu, J., Cross, N. B., Notaro, R., Lee, J. W., & Brodsky, R. A. (2026). Efficacy and safety of vemircopan as monotherapy in patients with paroxysmal nocturnal hemoglobinuria. Blood Advances. https://doi.org/10.1182/bloodadvances.2025017731
Source records
- crossref · retrieved 2026-09-27T05:02:44.013Z